Presentation is loading. Please wait.

Presentation is loading. Please wait.

נמטוציטים משושנת ים Eli. S Lec. No.2.

Similar presentations


Presentation on theme: "נמטוציטים משושנת ים Eli. S Lec. No.2."— Presentation transcript:

1 נמטוציטים משושנת ים Eli. S Lec. No.2

2 GLP Concerns as Per Schedule Drugs & Cosmetics הדרישות במעבדה
Storage and Archival General Requirements Premises Raw Data Personal Protocols and Specifications Archive Equipments GLP Chemicals and Reagents Standard Operating Procedures Good House Keeping and Safety Management Review Maintenance, Calibration, and Validation of Equipments Internal Quality System Audits Reference Materials Quality System Microbiological Cultures Eli. S Lec. No.2 2

3 GMP GMP Concerned with Production הדרישות בייצור
Buildings and Facilities Warehouse Facilities Sampling & Dispensing Manufacturing Areas IPQC areas Records and Reports Process Controls Cleaning Process Validation SOPs Reworks Ingredients controls Training Investigations Lab Controls Utilities Stability Programs Eli. S Lec. No.2

4 Investigational New Drug Application (IND) שלבים במחקר ופיתוח תרופה חדשה
Application to start clinical trials requires 3 main sections: CMC (manufacturing information) Preclinical and toxicology information Clinical protocol and investigator information Animal data must show drug is likely to be reasonably tolerated in humans (Show file 2019) Eli. S Lec. No.2

5 FDA Organization CBER - Center for Biologics Evaluation and Research
Office of Cellular, Tissue, and Gene Therapy Office of Vaccines Research and Review Office of Blood Research and Review CDER - Center for Drug Evaluation and Research CDRH - Center for Devices and Radiological Health CFSAN – Center for Food Safety and Applied Nutrition CVM – Center for Veterinary Medicine NCTR – National Center for Toxicological research Eli. S Lec. No.2

6 FDA = Food & Drug Administration
Eli. S Lec. No.2

7 Basic Disciplines of Drug Development המגמות בפיתוח תרופה
Chemistry, Manufacturing, and Controls (CMC) (Pre) Nonclinical Clinical Eli. S Lec. No.2

8 Office of New Drug Chemistry (ONDC) חשיבות המחקר הכימי
To ascertain the: identity, strength, quality & purity of the new drug product  includes evaluation of manufacturing process  stability program Eli. S Lec. No.2

9 What’s Important from a Chemistry Perspective?
Drug Substance (DS) can be quantitatively assayed in the Drug Product (DP). (drug product = drug substance + excipients) impurity profile of the DS: be determined be determined in the DP be qualified by Pharm. / Tox. reviewer Eli. S Lec. No.2

10 What’s Important from a Chemistry Perspective? (Cont’)
Stability of the DP be determined. i.e., the physico-chemical properties of the DP have not changed over shelf-life period / clinical trial. Analytical test procedures and acceptance criteria are indicative of product quality. Batch-to-batch variations are minimized by compliance with cGMP. Eli. S Lec. No.2

11 QUALITY SYSTEMS Broad systems of regulations, standards, or policies that ensure the quality of the final product GMP / GLP / GCP are examples of quality systems Eli. S Lec. No.2

12 GMP is actually Good Common Sense
Quality Management Quality Assurance GMP Production and Quality Control E. Solomon M.Sc, Lect. No. 5

13 QA, GMP & QC Inter-relationship
QC / GLP E. Solomon M.Sc, Lect. No. 5

14 WHAT IS PRODUCT QUALITY מהו איכות המוצר הביוטכנולוגי
What is a “good” product in Biotechnology That depends… Consider biotech: Research labs Testing labs Production facilities Eli. S Lec. No.2

15 QUALITY PRODUCT: RESEARCH LAB.
Research lab, knowledge is product: Knowledge of nature (basic research) Understanding of technology (applied research, R&D) Eli. S Lec. No.2

16 QUALITY SYSTEMS IN RESEARCH LAB
Quality system in research Ensure meaningful data has been around a long time It is called: DOING GOOD SCIENCE Eli. S Lec. No.2

17 “DOING GOOD SCIENCE” Less formalized than other quality systems
No laws to obey But it exists Eli. S Lec. No.2

18 INFORMAL SYSTEM Consequences of poor quality product not life-threatening so Government seldom involved in monitoring research quality Oversight not generally by outside inspectors or auditors Eli. S Lec. No.2

19 Oversight is by experts
THERE IS OVERSIGHT Oversight is by experts Grant review Publications Reputation Eli. S Lec. No.2

20 Good Laboratory Practices
A quality system concerned with the organizational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported. GLPs are regulations published in the Code of Federal Regulations (21CFR part 58) The OECD Principles of Good Laboratory Practice GLPs are not guidelines, they have the force of law. GLP’s are not “watered down” GMPs! Eli. S Lec. No.2

21 GLP - General Requirements
Appropriately qualified personnel Adequate resources Appropriate procedures for: Sanitation, health precautions, clothing Test protocol development, test methods Data analysis, report development Appropriately qualified study director Quality assurance function Eli. S Lec. No.2

22 Priority Essential Medicines
Eli. S Lec. No.2

23 GLP Reference Documents & Links (www.fda.gov/cder)
21 CFR 58 – Good Laboratory Practice for Non-clinical Laboratory Studies Div. of Scientific Investigations: Good Laboratory Practice BIMO Compliance Program Guidance A: GLP Program Eli. S Lec. No.2


Download ppt "נמטוציטים משושנת ים Eli. S Lec. No.2."

Similar presentations


Ads by Google